INTECH Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Sell
305,070
-146,451
-32% -$8.41M 0.16% 95
2026
Q1
$27.4M Sell
451,521
-643,255
-59% -$37.5M 0.27% 57
2025
Q4
$59.1M Buy
1,094,776
+931,322
+570% +$44.8M 0.53% 21
2025
Q3
$7.37M Sell
163,454
-9,655
-6% -$451K 0.07% 256
2025
Q2
$8.01M Sell
173,109
-32,961
-16% -$1.62M 0.08% 230
2025
Q1
$12.6M Buy
206,070
+34,184
+20% +$1.99M 0.13% 126
2024
Q4
$9.72M Sell
171,886
-217,624
-56% -$12.2M 0.09% 174
2024
Q3
$20.2M Sell
389,510
-94,869
-20% -$4.45M 0.23% 83
2024
Q2
$20.1M Sell
484,379
-220,228
-31% -$9.85M 0.25% 72
2024
Q1
$38.2M Buy
704,607
+314,732
+81% +$16M 0.54% 31
2023
Q4
$20M Sell
389,875
-283,629
-42% -$14.9M 0.29% 83
2023
Q3
$39.1M Sell
673,504
-647,149
-49% -$39.7M 0.58% 36
2023
Q2
$84.5M Sell
1,320,653
-569,405
-30% -$38.2M 0.87% 17
2023
Q1
$131M Sell
1,890,058
-17,246
-0.9% -$1.22M 1.06% 10
2022
Q4
$137M Sell
1,907,304
-103,784
-5% -$7.83M 1.03% 13
2022
Q3
$143M Buy
2,011,088
+315,484
+19% +$22.9M 1.07% 10
2022
Q2
$131M Buy
+1,695,604
New +$129M 0.75% 26

Other funds holding BMY

INTECH Investment Management's BMY Position: Q2 2026 in Review

INTECH Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q2 2026, selling an estimated $8.41M and leaving 305,070 shares worth $17.6M. The position accounts for 0.16% of the portfolio, ranked #95.

INTECH Investment Management first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $143M in Q3 2022. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • INTECH Investment Management held 305,070 shares of Bristol-Myers Squibb worth $17.6M as of Q2 2026.
  • INTECH Investment Management sold 146,451 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.41M.
  • Bristol-Myers Squibb made up 0.16% of INTECH Investment Management's portfolio in Q2 2026, its #95 holding.
  • INTECH Investment Management first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's Bristol-Myers Squibb position peaked at $143M in Q3 2022.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.